Clinical Trial Update: Comparison of Cilostazol-based Triple Antiplatelet Therapy Versus Dual Antiplatelet Therapy for Outcomes of below-the Knee Endovascular Intervention in Patients With Critical Limb Ischemia (TAP CLI Study) [Phase 4]

View source ↗

Summary

Clinical trial update comparing cilostazol-based triple antiplatelet therapy to dual antiplatelet therapy for below-the-knee endovascular interventions in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• cilostazol-based triple antiplatelet therapy (cilostazol-based triple antiplatelet therapy)
• dual antiplatelet therapy (dual antiplatelet therapy)

Snippet

Sponsor: Yonsei University | Conditions: Critical Limb Ischemia | Phase 4 | Status: UNKNOWN